# Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

> **NCT01121185** · PHASE2 · TERMINATED · sponsor: **MassBiologics** · enrollment: 13 (actual)

## Conditions studied

- HCV Infection
- Liver Transplantation

## Interventions

- **BIOLOGICAL:** MBL-HCV1
- **OTHER:** 0.9% Sodium chloride Placebo

## Key facts

- **NCT ID:** NCT01121185
- **Lead sponsor:** MassBiologics
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The study was terminated due to slower than anticipated subject accrual.
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121185, "Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01121185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*